Please use this identifier to cite or link to this item:
|Title:||Business model and product market strategy in Australian biotechnology entrepreneurial firms: exploratory study|
|Citation:||1st Annual Conference of the Academy of Innovation and Entrepreneurship, 27-29 March, 2008|
|Publisher:||Intellectual Property Publishing House|
|Conference Name:||Annual Conference of the Academy of Innovation and Entrepreneurship (1st : 2008 : Beijing, China)|
|Organisation:||Entrepreneurship, Commercialisation, and Innovation Centre|
|Abstract:||The business model (BM) concept is a relatively new subject of academic research, though the term has been used extensively by practitioners. Even with the rapid growth of publications in this area, there remains a vague boundary around the topic and no universally accepted classification. Large scale empirical research on the relative effectiveness of different models is at the infancy stage. This study follows the integrative theoretical approach suggested by Amit and Zott  and the empirical approach adopted in Zott and Amit  and Malone et al . We replicate  and extend it to Australian biotechnology IPOs in 1999-2004, testing the fit between BM design and product market strategies, and their effect on business performance. Early results suggest that the efficiency design theme is appropriate, but that complementary theory is required for a better fit with the industry’s characteristics|
|Keywords:||Business model; commercialization; entrepreneurship; biotechnology; IPO|
|Appears in Collections:||Entrepreneurship, Commercialisation, and Innovation Centre publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.